ArticleInternational journal of biological sciences2024

NK-92MI Cells Engineered with Anti-claudin-6 Chimeric Antigen Receptors in Immunotherapy for Ovarian Cancer.

Junping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.